BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 38536657)

  • 1. Response to [Challenging the Restrictive Approach: Reconsidering SGLT-2 Inhibitor Use in CKD].
    Tarun T; Davis OM; Ghanta SN; Jain N
    Kidney Int Rep; 2024 Jun; 9(6):1936. PubMed ID: 38899220
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythrocytosis and Polycythemia Secondary to Testosterone Replacement Therapy in the Aging Male.
    Jones SD; Dukovac T; Sangkum P; Yafi FA; Hellstrom WJ
    Sex Med Rev; 2015 Apr; 3(2):101-112. PubMed ID: 27784544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Sodium-Glucose Cotransporter-2 Inhibitors in Clinical Practice for Heart Failure Prevention and Treatment: Beyond Type 2 Diabetes. A Narrative Review.
    Rao S
    Adv Ther; 2022 Feb; 39(2):845-861. PubMed ID: 34881413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of erythrocytosis in men with type 2 diabetes treated with combined sodium-glucose cotransporter-2 inhibitor and testosterone replacement therapy.
    Gosmanov AR; Gemoets DE; Schumacher KA
    J Endocrinol Invest; 2024 Mar; ():. PubMed ID: 38536657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes.
    Zhuo M; Hawley CE; Paik JM; Bessette LG; Wexler DJ; Kim DH; Tong AY; Kim SC; Patorno E
    JAMA Netw Open; 2021 Oct; 4(10):e2130762. PubMed ID: 34705014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular protective effect of sodium-glucose cotransporter 2 inhibitors on patients with acute coronary syndrome and type 2 diabetes mellitus: a retrospective study.
    Chen J; Chang J; Shi Q; Li X; Wang L; Zhao H
    BMC Cardiovasc Disord; 2023 Oct; 23(1):495. PubMed ID: 37805494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy.
    Lundy SD; Parekh NV; Shoskes DA
    J Sex Med; 2020 Jul; 17(7):1297-1303. PubMed ID: 32307242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes.
    Marfella R; Prattichizzo F; Sardu C; Rambaldi PF; Fumagalli C; Marfella LV; La Grotta R; Frigé C; Pellegrini V; D'Andrea D; Cesaro A; Calabrò P; Pizzi C; Antonicelli R; Ceriello A; Mauro C; Paolisso G
    Cardiovasc Diabetol; 2024 Jan; 23(1):10. PubMed ID: 38184582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Italian Society of Andrology and Sexual Medicine (SIAMS), along with ten other Italian Scientific Societies, guidelines on the diagnosis and management of erectile dysfunction.
    Corona G; Cucinotta D; Di Lorenzo G; Ferlin A; Giagulli VA; Gnessi L; Isidori AM; Maiorino MI; Miserendino P; Murrone A; Pivonello R; Rochira V; Sangiorgi GM; Stagno G; Foresta C; Lenzi A; Maggi M; Jannini EA
    J Endocrinol Invest; 2023 Jun; 46(6):1241-1274. PubMed ID: 36698034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE).
    Isidori AM; Aversa A; Calogero A; Ferlin A; Francavilla S; Lanfranco F; Pivonello R; Rochira V; Corona G; Maggi M
    J Endocrinol Invest; 2022 Dec; 45(12):2385-2403. PubMed ID: 36018454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemochromatosis Gene Mutation in Persons Developing Erythrocytosis on Combined Testosterone and SGLT-2 Inhibitor Therapy.
    Schumacher KA; Gosmanov AR
    J Investig Med High Impact Case Rep; 2022; 10():23247096221111774. PubMed ID: 35848311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Dapagliflozin on Hematocrit in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From DECLARE-TIMI 58.
    Kolkailah AA; Wiviott SD; Raz I; Murphy SA; Mosenzon O; Bhatt DL; Leiter LA; Wilding JPH; Gause-Nilsson I; Sabatine MS; McGuire DK
    Diabetes Care; 2022 Feb; 45(2):e27-e29. PubMed ID: 35020832
    [No Abstract]   [Full Text] [Related]  

  • 13. JAK2 wild-type erythrocytosis associated with sodium-glucose cotransporter 2 inhibitor therapy.
    Gangat N; Szuber N; Alkhateeb H; Al-Kali A; Pardanani A; Tefferi A
    Blood; 2021 Dec; 138(26):2886-2889. PubMed ID: 34653249
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of metformin monotherapy in US veterans with type 2 diabetes and preexisting chronic kidney disease stage 3.
    Gosmanov AR; Gemoets DE; Kaminsky LS; Kovesdy CP; Gosmanova EO
    Diabetes Obes Metab; 2021 Aug; 23(8):1879-1885. PubMed ID: 33908689
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.